# EDGAR Filing Document

**Accession Number:** 0000768899
**File Stem:** 0000768899-26-000019
**Filing Date:** 2026-5
**Character Count:** 146349
**Document Hash:** bb13b6fb2ed570bbd6e3529d653bee0a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000768899-26-000019.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0000768899-26-000019

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 69

**CONFORMED PERIOD OF REPORT**: 20260329

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TrueBlue, Inc.
- **CENTRAL INDEX KEY:** 0000768899
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 911287341
- **STATE OF INCORPORATION:** WA
- **FISCAL YEAR END:** 1227

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14543
- **FILM NUMBER:** 26943891

**BUSINESS ADDRESS:**
- **STREET 1:** 1015 A STREET
- **CITY:** TACOMA
- **STATE:** WA
- **ZIP:** 98402
- **BUSINESS PHONE:** 253-383-9101

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 2910
- **STREET 2:** 1015 A. ST.
- **CITY:** TACOMA
- **STATE:** WA
- **ZIP:** 98402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LABOR READY INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DICKS HAMBURGERS INC
- **DATE OF NAME CHANGE:** 19900329

?xml version='1.0' encoding='ASCII'? tbi-20260329

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended: March 29, 2026

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

Commission File Number: 001-14543

____________________________________

![image0a22.jpg](tbi-20260329_g1.jpg)

**TrueBlue, Inc.** 

(Exact name of registrant as specified in its charter)

______________________________________

---

| | |
|:---|:---|
| **Washington** | **91-1287341** |
| (State of incorporation) | (I.R.S. employer identification no.) |

---

**1015 A Street, Tacoma, Washington 98402** 

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:**&nbsp;&nbsp;&nbsp;&nbsp;(253) 383-9101** 

______________________________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common stock, no par value** | **TBI** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ <br> Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 26, 2026, there were 30,404,091 shares of the registrant's common stock outstanding.

------

**TrueBlue, Inc.**

**Table of Contents**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** |
| **Item 1.** | <u>[Consolidated financial statements (unaudited)](#i063995e8228341da9579d946ba4e2af3_13)</u> | <u>[3](#i063995e8228341da9579d946ba4e2af3_13)</u> |
|  | <u>[Consolidated Balance Sheets](#i063995e8228341da9579d946ba4e2af3_16)</u> | <u>[3](#i063995e8228341da9579d946ba4e2af3_16)</u> |
|  | <u>[Consolidated Statements of Operations and Comprehensive Income (Loss)](#i063995e8228341da9579d946ba4e2af3_19)</u> | <u>[4](#i063995e8228341da9579d946ba4e2af3_19)</u> |
|  | <u>[Consolidated Statements of Cash Flows](#i063995e8228341da9579d946ba4e2af3_22)</u> | <u>[5](#i063995e8228341da9579d946ba4e2af3_22)</u> |
|  | <u>[Notes to consolidated financial statements](#i063995e8228341da9579d946ba4e2af3_25)</u> | <u>[6](#i063995e8228341da9579d946ba4e2af3_25)</u> |
| **Item 2.** | <u>[Management's discussion and analysis of financial condition and results of operations](#i063995e8228341da9579d946ba4e2af3_73)</u> | <u>[20](#i063995e8228341da9579d946ba4e2af3_73)</u> |
| **Item 3.** | <u>[Quantitative and qualitative disclosures about market risk](#i063995e8228341da9579d946ba4e2af3_103)</u> | <u>[30](#i063995e8228341da9579d946ba4e2af3_103)</u> |
| **Item 4.** | <u>[Controls and procedures](#i063995e8228341da9579d946ba4e2af3_106)</u> | <u>[30](#i063995e8228341da9579d946ba4e2af3_106)</u> |
| **PART II. OTHER INFORMATION** | **PART II. OTHER INFORMATION** | **PART II. OTHER INFORMATION** |
| **Item 1.** | <u>[Legal proceedings](#i063995e8228341da9579d946ba4e2af3_112)</u> | <u>[31](#i063995e8228341da9579d946ba4e2af3_112)</u> |
| **Item 1A.** | <u>[Risk factors](#i063995e8228341da9579d946ba4e2af3_115)</u> | <u>[31](#i063995e8228341da9579d946ba4e2af3_115)</u> |
| **Item 2.** | <u>[Unregistered sales of equity securities and use of proceeds](#i063995e8228341da9579d946ba4e2af3_121)</u> | <u>[31](#i063995e8228341da9579d946ba4e2af3_121)</u> |
| **Item 3.** | <u>[Defaults upon senior securities](#i063995e8228341da9579d946ba4e2af3_124)</u> | <u>[31](#i063995e8228341da9579d946ba4e2af3_124)</u> |
| **Item 4.** | <u>[Mine safety disclosures](#i063995e8228341da9579d946ba4e2af3_127)</u> | <u>[32](#i063995e8228341da9579d946ba4e2af3_127)</u> |
| **Item 5.** | <u>[Other information](#i063995e8228341da9579d946ba4e2af3_130)</u> | <u>[32](#i063995e8228341da9579d946ba4e2af3_130)</u> |
| **Item 6.** | <u>[Index to exhibits](#i063995e8228341da9579d946ba4e2af3_133)</u> | <u>[33](#i063995e8228341da9579d946ba4e2af3_133)</u> |
|  | <u>[Signatures](#i063995e8228341da9579d946ba4e2af3_136)</u> | <u>[34](#i063995e8228341da9579d946ba4e2af3_136)</u> |

---

Page - 2

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**PART I. FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **CONSOLIDATED FINANCIAL STATEMENTS** |

---

**TRUEBLUE, INC.**

**CONSOLIDATED BALANCE SHEETS**

***(unaudited)***

---

| | | |
|:---|:---|:---|
| ***(in thousands, except par value and share count data)*** | **March 29,<br>2026** | **December 28,<br>2025** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $24132 | $24510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance of $2,566 and $2,190, respectively | 246343 | 241233 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 29952 | 30987 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax receivable | 869 | 879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 301296 | 297609 |
| Property and equipment, net | 69462 | 73117 |
| Restricted cash, cash equivalents and investments | 129229 | 136588 |
| Deferred income taxes, net | 1243 | 1338 |
| Goodwill | 38930 | 42496 |
| Intangible assets, net | 17432 | 18095 |
| Operating lease right-of-use assets, net | 33028 | 34045 |
| Workers' compensation claims receivable, net | 20459 | 25659 |
| Other assets, net | 9589 | 9720 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $620668 | $638667 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other accrued expenses | $39811 | $36111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued wages and benefits | 65681 | 61736 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax payable | 1045 | 1038 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of workers' compensation claims reserve | 22931 | 24193 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current operating lease liabilities | 11095 | 11206 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 3302 | 4249 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 143865 | 138533 |
| Workers' compensation claims reserve, less current portion | 65170 | 72551 |
| Long-term debt | 73900 | 65800 |
| Long-term deferred compensation liabilities | 35438 | 39531 |
| Long-term operating lease liabilities | 45437 | 46796 |
| Other long-term liabilities | 776 | 899 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 364586 | 364110 |
| Commitments and contingencies (Note 9) |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.131 par value, 20,000,000 shares authorized; No shares issued and outstanding |  |  |
| Common stock, no par value, 100,000,000 shares authorized; 30,378,397 and 29,986,762 shares issued and outstanding | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (21686) | (21647) |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 277767 | 296203 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 256082 | 274557 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $620668 | $638667 |

---

*See accompanying notes to consolidated financial statements*

Page - 3

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**TRUEBLUE, INC.**

**CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)**

***(unaudited)***

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except per share data)*** | **March 29,<br>2026** | **March 30,<br>2025** |
| Revenue from services | $398566 | $370254 |
| Cost of services | 319547 | 283912 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 79019 | 86342 |
| Selling, general and administrative expense | 87299 | 94621 |
| Depreciation and amortization (exclusive of depreciation included in cost of services) | 5911 | 5844 |
| Goodwill impairment charge | 3656 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (17847) | (14123) |
| Interest and other income (expense), net | (1372) | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss before tax expense | (19219) | (13930) |
| Income tax expense | 576 | 418 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(19795) | $(14348) |
| Net loss per common share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.66) | $(0.48) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.66) | $(0.48) |
| Weighted average shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 30145 | 29698 |
| &nbsp;&nbsp;&nbsp;Diluted | 30145 | 29698 |
| Other comprehensive loss: |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | $(39) | $(29) |
| Comprehensive loss | $(19834) | $(14377) |

---

*See accompanying notes to consolidated financial statements*

Page - 4

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**TRUEBLUE, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

***(unaudited)***

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands)*** | **March 29,<br>2026** | **March 30,<br>2025** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(19795) | $(14348) |
| &nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization (inclusive of depreciation included in cost of services) | 6867 | 6810 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment charge | 3656 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 1074 | 250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 1793 | 2060 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 195 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expense | 2613 | 2753 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating activities | 1982 | 1486 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (6052) | 9133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable and payable |  | 373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 7003 | 7150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other accrued expenses | 4002 | (9580) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued wages and benefits | 3946 | (5418) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Workers' compensation claims reserve | (8643) | (16865) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (3034) | (3035) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | (5386) | (2884) |
| Net cash used in operating activities | (9779) | (22115) |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Capital expenditures | (2829) | (4680) |
| &nbsp;&nbsp;&nbsp;Acquisition of business, net of cash acquired |  | (30044) |
| &nbsp;&nbsp;&nbsp;Purchases of restricted held-to-maturity investments | (7718) |  |
| &nbsp;&nbsp;Sales and maturities of restricted held-to-maturity investments | 13768 | 10756 |
| Net cash provided by (used in) investing activities | 3221 | (23968) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net proceeds from employee stock purchase plans | 162 | 70 |
| &nbsp;&nbsp;&nbsp;Common stock repurchases for taxes upon vesting of restricted stock | (597) | (895) |
| &nbsp;&nbsp;&nbsp;Net change in revolving credit facility | 8100 | 50200 |
| &nbsp;&nbsp;&nbsp;Other | (491) | (6) |
| Net cash provided by financing activities | 7174 | 49369 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | (323) | (230) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in cash, cash equivalents and restricted cash and cash equivalents | 293 | 3056 |
| Cash, cash equivalents and restricted cash and cash equivalents, beginning of period | 44020 | 61100 |
| Cash, cash equivalents and restricted cash and cash equivalents, end of period | $44313 | $64156 |
| *Supplemental disclosure of cash flow information:* |  |  |
| &nbsp;&nbsp;Cash paid during the period for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest | $1563 | $355 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes, net of refunds | $378 | $116 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | $3751 | $3593 |
| &nbsp;&nbsp;&nbsp;Non-cash transactions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment purchased but not yet paid | $553 | $1305 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets obtained in exchange for new operating lease liabilities | $1830 | $1454 |

---

*See accompanying notes to consolidated financial statements*

Page - 5

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 1:&nbsp;&nbsp;&nbsp;&nbsp;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Financial statement preparation***

The accompanying unaudited consolidated financial statements ("financial statements") of TrueBlue, Inc. (the "Company," "TrueBlue," "we," "us," and "our") are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial information. Accordingly, certain information and footnote disclosures usually found in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial statements reflect all adjustments which, in the opinion of management, are necessary to fairly state the financial statements for the interim periods presented. We follow the same accounting policies for preparing both quarterly and annual financial statements.

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. The results of operations for the thirteen weeks ended March 29, 2026 are not necessarily indicative of the results expected for the full fiscal year nor for any other fiscal period.

These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 28, 2025.

***Goodwill***

We evaluate goodwill for impairment on an annual basis as of the first day of our fiscal second quarter, or whenever events or circumstances make it more likely than not that an impairment may have occurred. These events or circumstances could include a significant change in general economic conditions, deterioration in industry environment, changes in cost factors, declining operating performance indicators, legal factors, competition, client engagement, changes in the carrying amount of net assets, a sale or disposition of a significant portion of a reporting unit, or a sustained decrease in stock price. We monitor the existence of potential impairment indicators throughout the fiscal year.

***Goodwill***

We test for goodwill impairment at the reporting unit level. We consider our reporting units to be our operating segments or one level below (the component level) based on our organizational structure. Our reporting units with remaining goodwill as of March 29, 2026 were Centerline, PeopleScout, and Healthcare Staffing Professionals ("HSP").

When evaluating goodwill for impairment, we may first assess qualitative factors to determine whether it is more likely than not the fair value of a reporting unit is less than its carrying amount. Qualitative factors include macroeconomic conditions, industry and market conditions, and overall company financial performance. If, after assessing the totality of events and circumstances, we determine that it is more likely than not the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary.

The quantitative impairment test, if necessary, involves comparing the fair value of each reporting unit to its carrying value, including goodwill. Fair value reflects the price a market participant would be willing to pay in a potential sale of the reporting unit. If the fair value exceeds the carrying value, we conclude that no goodwill impairment has occurred. If the carrying value of the reporting unit exceeds its fair value, we recognize an impairment loss in an amount equal to the excess, not to exceed the carrying value of the goodwill. We consider a reporting unit's fair value to be substantially in excess of its carrying value at a 20% premium or greater.

Refer to Note 6: *Goodwill* for details on the interim impairment test, the impairment charge, valuation methodologies, and inputs used in the fair value measurement.

***Recently adopted accounting standards***

There were no new accounting standards adopted during the thirteen weeks ended March 29, 2026 that had a material impact on our financial statements.

Page - 6

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

***Recently issued accounting standards and disclosure rules not yet adopted***

***Disaggregation of income statement expenses***

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, "Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses," and in January 2025, the FASB issued ASU 2025-01, "Income Statement (Subtopic 220-40): Clarifying the Effective Date." ASU 2024-03 requires disclosures about specific types of expenses included in the expense captions presented in the income statement as well as disclosure about selling expenses. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026 (fiscal 2027 for TrueBlue) and interim periods beginning after December 15, 2027 (fiscal Q1 2028 for TrueBlue) on a prospective or retrospective basis. We are currently evaluating the impact of this ASU on our required disclosures.

***Internal-use software***

In September 2025, the FASB issued ASU 2025-06, "Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40) - Targeted Improvements to the Accounting for Internal-Use Software." This ASU eliminates references to project stages and instead requires an entity to start capitalizing software costs once both of the following criteria have been met: (1) management has authorized and committed to funding the software project, and (2) it is probable that the project will be completed and the software will be used for its intended function. This ASU is effective for fiscal years beginning after December 15, 2027 (fiscal 2028 for TrueBlue) and interim reporting periods within those annual reporting periods (fiscal Q1 2028 for TrueBlue). The guidance can be applied on a prospective basis, a modified basis for in-process projects or on a retrospective basis, and early adoption is permitted. We are currently evaluating the impact of this ASU; however, it is not anticipated to have a material impact on our consolidated financial statements.

***Interim reporting***

In December 2025, the FASB issued ASU 2025-11, "Interim Reporting (Topic 270) - Narrow-Scope Improvements." This ASU clarifies interim disclosure requirements, provides a comprehensive list of interim disclosure requirements within Topic 270, and introduces a disclosure principle to help entities determine which events since the end of the last annual reporting period are material for disclosure. This ASU does not change the fundamental nature of interim reporting or expand or reduce existing interim disclosure requirements. This ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027 (fiscal Q1 2028 for TrueBlue). The guidance can be applied on a prospective basis, or a retrospective basis for all or any prior periods, and early adoption is permitted. We are currently evaluating the impact of this ASU; however, it is not anticipated to have a material impact on our consolidated financial statements.

***Government assistance***

In December 2025, the FASB issued ASU 2025-10, "Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities." This ASU provides authoritative guidance for the recognition, measurement and presentation of government grants received by a business entity. This ASU is effective for annual reporting periods beginning after December 15, 2028 (fiscal 2029 for TrueBlue) and interim periods within those annual periods (fiscal Q1 2029 for TrueBlue). The guidance can be applied on a modified prospective, modified retrospective, or retrospective basis; early adoption is permitted. We are currently evaluating the impact of this ASU on our consolidated financial statements and related disclosures.

Page - 7

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 2:&nbsp;&nbsp;&nbsp;&nbsp;ACQUISITION**

Effective January 31, 2025, we acquired all of the outstanding equity interests of Healthcare Staffing Professionals, Inc., a long-term staffing and permanent hiring solutions provider, primarily focused on healthcare positions in the U.S. This acquisition allows us to expand revenue in the healthcare end-market while also diversifying our business.

Under the terms of the share purchase agreement, the base purchase price of $42.0 million was adjusted for estimated unpaid pre-close liabilities of the selling shareholders, cash acquired and estimated excess working capital. The purchase price allocated to acquired assets and liabilities was cash consideration of $35.2 million. As part of the share purchase agreement, certain Healthcare Staffing Professionals, Inc. employees can earn up to an additional $14.0 million based on the financial performance of the business over the next two years, which we have concluded would be treated as compensation expense. We have not recorded any contingent compensation expense associated with this acquisition, since we do not anticipate that this contingent compensation will be earned as of March 29, 2026. Any amounts probable of being paid out under the agreement are expensed over the required service period. We incurred acquisition-related costs of $0.7 million for the thirteen weeks ended March 30, 2025, which are included in SG&A expense on the Consolidated Statements of Operations and Comprehensive Income (Loss).

The following table reflects our final allocation of the purchase price to the fair value of assets acquired and liabilities assumed:

---

| | |
|:---|:---|
| ***(in thousands)*** | **Purchase price allocation** |
| *Purchase price allocated as follows:* |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $5042 |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 13877 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses, deposits and other current assets | 216 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 97 |
| &nbsp;&nbsp;&nbsp;Intangible assets | 14950 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets acquired | 34182 |
| &nbsp;&nbsp;&nbsp;Accounts payable and other accrued expenses | 2228 |
| &nbsp;&nbsp;&nbsp;Accrued wages and benefits | 10369 |
| &nbsp;&nbsp;&nbsp;Income tax payable | 3635 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | 97 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities assumed | 16329 |
| &nbsp;&nbsp;&nbsp;Net identifiable assets acquired | 17853 |
| &nbsp;&nbsp;&nbsp;Goodwill (1) | 17338 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cash consideration transferred | $35191 |

---

(1) Goodwill represents the expected synergies with our existing businesses, the acquired assembled workforce, potential new clients and future cash flows after the acquisition of Healthcare Staffing Professionals, Inc., and is deductible for income tax purposes. We performed an interim goodwill impairment test associated with our HSP reporting unit as of the last day of our fiscal first quarter of 2026, which resulted in an impairment charge of $3.7 million. Goodwill remaining for the HSP reporting unit as of March 29, 2026 is $13.7 million. Refer to Note 6: *Goodwill* for additional details.

Intangible assets include identifiable intangible assets for customer relationships and trade names/trademarks. We estimated the fair value of the acquired identifiable intangible assets, which are subject to straight line amortization, using an income approach. These fair value measurements were based on Level 3 inputs under the fair value hierarchy.

The following table sets forth the components of identifiable intangible assets acquired, including immaterial measurement period adjustments, as of January 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in thousands, except percentages and estimated useful lives, in years)*** | **Estimated fair value** | **Estimated useful life in years** | **Valuation method** | **Discount rate** |
| Customer relationships | $14300 | 6 | Multi-period excess earnings | 17.0% |
| Trade names/trademarks | 650 | 7 | Relief from royalty | 17.0% |
| &nbsp;&nbsp;&nbsp;Total acquired identifiable intangible assets | $14950 |  |  |  |

---

Page - 8

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

The acquired assets and assumed liabilities of Healthcare Staffing Professionals, Inc. are included on our Consolidated Balance Sheets as of March 29, 2026 and December 28, 2025, and the results of its operations are reported on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen weeks ended March 29, 2026 and for the period from February 1, 2025 to March 30, 2025. The amount of revenue for Healthcare Staffing Professionals, Inc. included on our Consolidated Statements of Operations and Comprehensive Income (Loss) was $12.4 million and $11.3 million for the thirteen weeks ended March 29, 2026 and March 30, 2025, respectively. The amount of income (loss) from operations for Healthcare Staffing Professionals, Inc. included on our Consolidated Statements of Operations and Comprehensive Income (Loss) was $(3.3) million and $0.2 million for the thirteen weeks ended March 29, 2026 and March 30, 2025, respectively. Income (loss) from operations includes a goodwill impairment charge of $3.7 million for the thirteen weeks ended March 29, 2026. Refer to Note 6: *Goodwill* for additional details. Healthcare Staffing Professionals, Inc. results have been combined with our historical PeopleScout segment, which was renamed PeopleSolutions in fiscal 2025. We concluded the acquisition of Healthcare Staffing Professionals, Inc. was not material to our consolidated results of operations and, as such, pro forma financial information was not required.

 **NOTE 3:&nbsp;&nbsp;&nbsp;&nbsp;FAIR VALUE MEASUREMENT**

Accounts receivable, accounts payable and other accrued expenses, accrued wages and benefits and related taxes approximate their fair values due to the short-term maturities of these assets and liabilities. Our long-term debt is related to a revolving credit agreement and its carrying value approximates fair value as the interest rates are variable and reflect current market rates.

***Assets measured at fair value on a recurring basis***

Our assets measured at fair value on a recurring basis consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 29, 2026** | **March 29, 2026** | **March 29, 2026** | **March 29, 2026** |
|<br>***(in thousands)*** | **Total fair value** | **Quoted prices in active markets for identical assets (level 1)** | **Significant other observable inputs (level 2)** | **Significant unobservable inputs (level 3)** |
| Cash and cash equivalents | $24132 | $24132 | $— | $— |
| Restricted cash and cash equivalents | 20181 | 20181 |  |  |
| &nbsp;&nbsp;Cash, cash equivalents and restricted cash and cash equivalents (1) | $44313 | $44313 | $— | $— |
| Municipal debt securities | $5797 | $— | $5797 | $— |
| Corporate debt securities | 42658 |  | 42658 |  |
| Agency mortgage-backed securities | 4594 |  | 4594 |  |
| U.S. government and agency securities | 11680 |  | 11680 |  |
| &nbsp;&nbsp;&nbsp;Restricted investments classified as held-to-maturity (2) | $64729 | $— | $64729 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 28, 2025** | **December 28, 2025** | **December 28, 2025** | **December 28, 2025** |
|<br>***(in thousands)*** | **Total fair value** | **Quoted prices in active markets for identical assets (level 1)** | **Significant other observable inputs (level 2)** | **Significant unobservable inputs (level 3)** |
| Cash and cash equivalents | $24510 | $24510 | $— | $— |
| Restricted cash and cash equivalents | 19510 | 19510 |  |  |
| &nbsp;&nbsp;Cash, cash equivalents and restricted cash and cash equivalents (1) | $44020 | $44020 | $— | $— |
| Municipal debt securities | $7836 | $— | $7836 | $— |
| Corporate debt securities | 50334 |  | 50334 |  |
| Agency mortgage-backed securities | 4873 |  | 4873 |  |
| U.S. government and agency securities | 7973 |  | 7973 |  |
| &nbsp;&nbsp;&nbsp;Restricted investments classified as held-to-maturity (2) | $71016 | $— | $71016 | $— |

---

(1)Cash, cash equivalents and restricted cash and cash equivalents include money market funds, deposits and investments with original maturities of three months or less.

(2)Refer to Note 4: *Restricted Cash, Cash Equivalents and Investments* for additional details on our held-to-maturity debt securities.

Page - 9

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

***Assets measured at fair value on a nonrecurring basis***

In addition to assets that are recorded at fair value on a recurring basis, impairment tests may subject our reporting units with goodwill to nonrecurring fair value measurement. We performed an interim impairment test for goodwill associated with our HSP reporting unit as of the last day of our fiscal first quarter of 2026. Refer to Note 6: *Goodwill* for additional details on the impairment charge, valuation methodologies, and inputs used in the fair value measurement.

For our interim goodwill impairment test on the HSP reporting unit as of the last day of our fiscal first quarter of 2026, the fair value of the reporting unit was estimated using an equal weighting of the income and market approaches. The various inputs to the fair value model are considered Level 3. As a result of the test, goodwill with a carrying value of $17.3 million associated with our HSP reporting unit was impaired, and an impairment charge of $3.7 million was recognized on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen weeks ended March 29, 2026.

**NOTE 4:&nbsp;&nbsp;&nbsp;&nbsp;RESTRICTED CASH, CASH EQUIVALENTS AND INVESTMENTS**

The following is a summary of the carrying value of our restricted cash, cash equivalents and investments:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **March 29,<br>2026** | **December 28,<br>2025** |
| Cash collateral held by insurance carriers | $7708 | $7681 |
| Cash and cash equivalents held in Trust | 11684 | 11424 |
| Investments held in Trust | 64616 | 70601 |
| Company-owned life insurance policies | 44432 | 46477 |
| Other restricted cash and cash equivalents | 789 | 405 |
| &nbsp;&nbsp;Total restricted cash, cash equivalents and investments | $129229 | $136588 |

---

***Held-to-maturity***

Restricted cash, cash equivalents and investments include collateral that has been provided or pledged to insurance carriers for workers' compensation and state workers' compensation programs. Our insurance carriers and certain state workers' compensation programs require us to collateralize a portion of our workers' compensation obligation. The collateral typically takes the form of cash and cash equivalents and highly rated investment grade securities, primarily in debt and asset-backed securities. The majority of our collateral obligations are held in a trust at the Bank of New York Mellon ("Trust").

The amortized cost and estimated fair value of each of our held-to-maturity investments held in Trust, aggregated by investment category as of March 29, 2026 and December 28, 2025, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 29, 2026** | **March 29, 2026** | **March 29, 2026** | **March 29, 2026** |
|<br>***(in thousands)*** | **Amortized cost** | **Gross unrealized gains** | **Gross unrealized losses** | **Fair value** |
| Municipal debt securities | $5799 | $— | $(2) | $5797 |
| Corporate debt securities | 42527 | 235 | (104) | 42658 |
| Agency mortgage-backed securities | 4564 | 30 |  | 4594 |
| U.S. government and agency securities | 11726 |  | (46) | 11680 |
| &nbsp;&nbsp;&nbsp;Total held-to-maturity investments | $64616 | $265 | $(152) | $64729 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 28, 2025** | **December 28, 2025** | **December 28, 2025** | **December 28, 2025** |
|<br>***(in thousands)*** | **Amortized cost** | **Gross unrealized gains** | **Gross unrealized losses** | **Fair value** |
| Municipal debt securities | $7840 | $1 | $(5) | $7836 |
| Corporate debt securities | 49967 | 519 | (152) | 50334 |
| Agency mortgage-backed securities | 4815 | 58 |  | 4873 |
| U.S. government and agency securities | 7979 | 1 | (7) | 7973 |
| &nbsp;&nbsp;&nbsp;Total held-to-maturity investments | $70601 | $579 | $(164) | $71016 |

---

Page - 10

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

The amortized cost and fair value by contractual maturity of our held-to-maturity investments are as follows:

---

| | | |
|:---|:---|:---|
| | **March 29, 2026** | **March 29, 2026** |
|<br>***(in thousands)*** | **Amortized cost** | **Fair value** |
| Due in one year or less | $36587 | $36545 |
| Due after one year through five years | 28029 | 28184 |
| &nbsp;&nbsp;&nbsp;Total held-to-maturity investments | $64616 | $64729 |

---

Actual maturities may differ from contractual maturities because the issuers of certain debt securities have the right to call or prepay their obligations without penalty. We have no significant concentrations of counterparties in our held-to-maturity investment portfolio.

***Company-owned life insurance policies***

We hold company-owned life insurance policies to support our deferred compensation liability. Unrealized gains and losses related to investments still held at March 29, 2026 and March 30, 2025, which are included in selling, general and administrative ("SG&A") expense on our Consolidated Statements of Operations and Comprehensive Income (Loss), were as follows:

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands)*** | **March 29,<br>2026** | **March 30,<br>2025** |
| Unrealized loss, net | $(2045) | $(1405) |

---

**NOTE 5:&nbsp;&nbsp;&nbsp;&nbsp;SUPPLEMENTAL BALANCE SHEET INFORMATION**

***Accounts receivable allowance for credit losses***

The activity related to the accounts receivable allowance for credit losses was as follows:

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands)*** | **March 29,<br>2026** | **March 30,<br>2025** |
| Beginning balance | $2190 | $1009 |
| Current period provision | 1074 | 250 |
| Write-offs | (698) | (398) |
| Foreign currency translation |  |  |
| &nbsp;&nbsp;&nbsp;Ending balance | $2566 | $861 |

---

***Prepaid expenses and other current assets***

The balance of prepaid expenses and other current assets was made up of the following:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **March 29,<br>2026** | **December 28,<br>2025** |
| Prepaid software agreements | $8537 | $6997 |
| Other prepaid expenses | 6278 | 7484 |
| Assets held-for-sale | 11759 | 11759 |
| Other current assets | 3378 | 4747 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | $29952 | $30987 |

---

***Assets held-for-sale***

As of March 29, 2026 and December 28, 2025, all criteria for classifying our Tacoma headquarters office building as held-for-sale were met. The sale is expected to be finalized within one year, subject to customary closing conditions. The estimated fair value of the disposal group, less costs to sell, continues to exceed its carrying value of $11.8 million, and therefore no impairment charge was recorded during the thirteen weeks ended March 29, 2026.

Page - 11

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 6:&nbsp;&nbsp;&nbsp;&nbsp;GOODWILL**

***Goodwill***

The following table reflects changes in the carrying amount of goodwill during the period by reportable segment:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ***(in thousands)*** | ***(in thousands)*** | **PeopleReady** | **PeopleManagement** | **PeopleSolutions** | **Total company** |
| Balance at | December 28, 2025 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Goodwill before impairment | &nbsp;&nbsp;&nbsp;Goodwill before impairment | $105284 | $81092 | $159647 | $346023 |
| &nbsp;&nbsp;&nbsp;Accumulated impairment charge | &nbsp;&nbsp;&nbsp;Accumulated impairment charge | (105284) | (79601) | (118642) | (303527) |
| Goodwill | Goodwill |  | 1491 | 41005 | 42496 |
| Impairment charge | Impairment charge |  |  | (3656) | (3656) |
| Foreign currency translation | Foreign currency translation |  |  | 90 | 90 |
| Balance at | March 29, 2026 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Goodwill before impairment | &nbsp;&nbsp;&nbsp;Goodwill before impairment | 105284 | 81092 | 159737 | 346113 |
| &nbsp;&nbsp;&nbsp;Accumulated impairment charge | &nbsp;&nbsp;&nbsp;Accumulated impairment charge | (105284) | (79601) | (122298) | (307183) |
| Goodwill | Goodwill | $— | $1491 | $37439 | $38930 |

---

During the thirteen weeks ended March 29, 2026, management determined that a triggering event occurred at our HSP reporting unit as a result of a lower share price and market capitalization. An additional impairment indicator was downward revisions to future projections, as a result of reductions in government funding that has impacted certain HSP clients. Therefore, we performed an interim goodwill impairment test for this reporting unit as of the last day of our fiscal first quarter of 2026. The fair value of the reporting unit was estimated using a weighting of the income and market valuation approaches. The income approach applied a fair value methodology to the reporting unit based on discounted cash flows. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internally-developed forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested. The weighted average cost of capital used in our most recent impairment test was 16.5%. We also applied a market approach, which develops a value correlation based on the market capitalization of similar publicly traded companies, referred to as a multiple, to apply to the operating results of the reporting units. The primary market multiples to which we compare are revenue and earnings before interest, taxes, depreciation, and amortization. In our most recent interim impairment test associated with our HSP reporting unit, the market multiples were based on revenue. The income and market approaches were equally weighted in our most recent interim impairment test.

Based on our interim impairment test as of the last day of our fiscal first quarter of 2026, we concluded that the carrying amount of the HSP reporting unit exceeded its estimated fair value. Thus, we recorded a non-cash goodwill impairment charge of $3.7 million, which was included in goodwill impairment charge on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen weeks ended March 29, 2026. The goodwill impairment was primarily driven by downward revisions to future projections associated with our HSP reporting unit, an increase in discount rate, and a decline in market capitalization of similar publicly traded companies. The remaining goodwill balance for HSP as of March 29, 2026 was $13.7 million. Any significant adverse change in our near- or long-term projections or macroeconomic conditions could result in future impairment charges. We will continue to closely monitor the operational performance of this reporting unit.

Page - 12

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 7:&nbsp;&nbsp;&nbsp;&nbsp;WORKERS' COMPENSATION INSURANCE AND RESERVES**

We provide workers' compensation insurance for our associates and permanent employees. The majority of our current workers' compensation insurance policies cover claims for a particular event above our $5.0 million deductible limit, on a "per occurrence" basis. This results in our business being substantially self-insured.

Our workers' compensation reserve for claims below the deductible limit is discounted to its estimated net present value. The discount rates used to estimate net present value are based on average returns of "risk-free" U.S. Treasury instruments available during the year in which the liability was incurred and the weighted average duration of the payments against the self-insured claims. Payments made against self-insured claims are made over a weighted average period of approximately 3 years as of March 29, 2026. The weighted average discount rate was 3.1% and 3.1% at March 29, 2026 and December 28, 2025, respectively.

The following table presents a reconciliation of the undiscounted workers' compensation reserve to the discounted workers' compensation reserve for the periods presented:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **March 29,<br>2026** | **December 28,<br>2025** |
| Undiscounted workers' compensation reserve (1) | $97603 | $107480 |
| Less discount on workers' compensation reserve | 9502 | 10736 |
| &nbsp;&nbsp;&nbsp;Workers' compensation reserve, net of discount | 88101 | 96744 |
| Less current portion | 22931 | 24193 |
| &nbsp;&nbsp;&nbsp;Long-term portion | $65170 | $72551 |

---

(1)Amounts shown are net of discount related to claims above our self-insured limits ("excess claims").

Payments made against self-insured claims were $12.0 million and $10.6 million for the thirteen weeks ended March 29, 2026 and March 30, 2025, respectively.

Our workers' compensation reserve includes estimated expenses related to claims above our self-insured limits ("excess claims"), and we record a corresponding receivable for the insurance coverage on excess claims based on the contractual policy agreements we have with insurance carriers. We discount this reserve and corresponding receivable to its estimated net present value using the discount rates based on average returns of "risk-free" U.S. Treasury instruments available during the year in which the liability was incurred and the weighted average duration of the payments against the excess claims. The discounted workers' compensation reserve for excess claims was $20.5 million and $25.7 million as of March 29, 2026 and December 28, 2025, respectively. The discounted receivables from insurance companies, net of valuation allowance, were $20.5 million and $25.7 million as of March 29, 2026 and December 28, 2025, respectively.

Workers' compensation cost consists primarily of changes in self-insurance reserves net of changes in discount, monopolistic jurisdictions' premiums, insurance premiums and other miscellaneous expenses. Workers' compensation cost of $10.1 million and $1.2 million was recorded in cost of services on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen weeks ended March 29, 2026 and March 30, 2025, respectively.

Page - 13

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 8:&nbsp;&nbsp;&nbsp;&nbsp;LONG-TERM DEBT**

We have a revolving credit agreement with Bank of America, N.A., PNC Bank, N.A., HSBC Bank USA, N.A., Wells Fargo Bank, N.A., and Key Bank, N.A. dated as of February 9, 2024 (the "Revolving Credit Facility" and, as amended by the Second Amendment (as defined below), the "Amended Revolving Credit Facility"), which is set to mature on February 9, 2029. The Revolving Credit Facility, as amended by the Second Amendment to Amended and Restated Credit Agreement dated January 30, 2026 (the "Second Amendment"), provides for a revolving line of credit of up to $175.0 million. We have an option to increase the amount by $150.0 million, subject to lender approval. Included in the Amended Revolving Credit Facility is a $25.0 million sub-limit for swingline loans and a $25.0 million sub-limit for letters of credit.

The maximum amount we can borrow under the Amended Revolving Credit Facility is subject to a borrowing base and minimum excess availability covenant. The borrowing base is determined by eligible receivable accounts as defined in the Second Amendment, less specific availability reserves. The minimum excess availability covenant is the greater of (a) 12.5% of the lesser of the borrowing base or the total line of credit and (b) $17.5 million. The minimum excess availability covenant may subsequently be replaced with a springing fixed charge coverage ratio covenant upon the satisfaction of meeting a minimum fixed charge coverage ratio test for two consecutive quarters occurring on or after September 27, 2026. The fixed charge coverage ratio covenant will thereafter apply when excess availability is below certain thresholds.

The following table presents the balances of the Revolving Credit Facility and Amended Revolving Credit Facility, as applicable:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **March 29,<br>2026** | **December 28,<br>2025** |
| Term SOFR Loans (1) | $62500 | $40000 |
| Base Rate Loan |  | 5000 |
| Swingline loans | 11400 | 20800 |
| &nbsp;&nbsp;&nbsp;Long-term debt | 73900 | 65800 |
| Letters of credit | 11372 | 11386 |
| &nbsp;&nbsp;&nbsp;Total outstanding | $85272 | $77186 |

---

(1)One-month Term Secured Overnight Financing Rate ("SOFR") Loans.

As of March 29, 2026, the borrowing base in effect was $121.3 million, leaving $36.0 million of unused borrowing base available.

Under the terms of the Amended Revolving Credit Facility, we have the option to borrow funds under the revolving line of credit as a Term SOFR Loan, for a one-, three- or six-month term, or as a Base Rate Loan, as defined in the Amended Revolving Credit Facility. Under a Term SOFR Loan, we are required to pay a variable rate of interest on funds borrowed based on the Term SOFR Screen Rate two days prior for the equivalent term, plus an adjustment of 0.10%, plus an applicable spread between 1.75% and 3.50%. Under a Base Rate Loan we are required to pay a variable rate of interest on funds borrowed based on a base rate plus an applicable spread between 0.75% and 2.50%. The base rate is the greater of the one-month Term SOFR Screen Rate two days prior plus 1.00%, the prime rate (as announced by Bank of America), or the federal funds rate plus 0.50%. The applicable spread is determined by the consolidated leverage ratio, as defined in the Amended Revolving Credit Facility. As of March 29, 2026, the outstanding balance under Term SOFR loans carried an applicable spread on the base rate of 3.50% and a weighted average base rate of 3.77%, resulting in a weighted average interest rate of 7.27%. The Term SOFR loans were primarily used to fund the acquisition of Healthcare Staffing Professionals, Inc. in the fiscal first quarter of 2025, and to support working capital requirements as revenue increased.

Under a swingline loan, we are required to pay a variable rate of interest on funds borrowed based on the base rate plus applicable spread between 0.75% and 2.50%, as described above. As of March 29, 2026, the applicable spread on the base rate was 2.50% and the base rate was 6.75%, resulting in an interest rate of 9.25%.

A commitment fee between 0.35% and 0.50% is applied against the Amended Revolving Credit Facility's unused borrowing capacity, with the specific rate determined by the consolidated leverage ratio, as defined in the Amended Revolving Credit Facility. Letters of credit are priced at a margin between 1.50% and 3.25%, with the specific rate determined by the consolidated leverage ratio, plus a fronting fee of 0.25%.

Page - 14

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

Obligations under the Amended Revolving Credit Facility are guaranteed by TrueBlue and material U.S. domestic subsidiaries, and are secured by substantially all of the assets of TrueBlue and material U.S. domestic subsidiaries. The Amended Revolving Credit Facility contains customary representations and warranties, events of default, and affirmative and negative covenants, including, among others, financial covenants.

As of March 29, 2026, we remain in compliance with all the requirements of the Amended Revolving Credit Facility.

**NOTE 9:&nbsp;&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES**

***Workers' compensation commitments***

We have provided our insurance carriers and certain states with commitments in the form and amounts listed below:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **March 29,<br>2026** | **December 28,<br>2025** |
| Cash collateral held by workers' compensation insurance carriers | $3403 | $3376 |
| Cash and cash equivalents held in Trust | 11684 | 11424 |
| Investments held in Trust | 64616 | 70601 |
| Letters of credit (1) | 3150 | 3385 |
| Surety bonds (2) | 21216 | 21116 |
| &nbsp;&nbsp;&nbsp;Total collateral commitments | $104069 | $109902 |

---

(1)We have agreements with certain financial institutions to issue letters of credit as collateral.

(2)Our surety bonds are issued by independent insurance companies on our behalf and bear annual fees based on a percentage of the bond, which are determined by each independent surety carrier. These fees do not exceed 2.0% of the bond amount, subject to a minimum charge. The terms of these bonds are subject to review and renewal every one to four years and most bonds can be canceled by the sureties with as little as 60 days' notice.

***Legal contingencies and developments***

We are involved in various proceedings arising in the normal course of conducting business. We believe the liabilities included in our financial statements reflect the probable loss that can be reasonably estimated and are immaterial. We also believe that the aggregate range of reasonably possible losses for the Company's exposure in excess of the amount accrued is expected to be immaterial to the Company. It remains possible that despite our current belief, material differences in actual outcomes or changes in management's evaluation or predictions could arise that could have a material effect on the Company's financial condition, results of operations or cash flows.

Page - 15

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 10:&nbsp;&nbsp;&nbsp;&nbsp;SHAREHOLDERS' EQUITY**

Changes in the balance of each component of shareholders' equity during the reporting periods were as follows:

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands)*** | **March 29,<br>2026** | **March 30,<br>2025** |
| **Common stock shares** | | |
| Beginning balance | 29987 | 29588 |
| Net issuance under equity plans | 391 | 245 |
| &nbsp;&nbsp;&nbsp;Ending balance | 30378 | 29833 |
| **Common stock amount** |  |  |
| Beginning balance | $1 | $1 |
| Current period activity |  |  |
| &nbsp;&nbsp;&nbsp;Ending balance | 1 | 1 |
| **Retained earnings** |  |  |
| Beginning balance | 296203 | 337551 |
| Net loss | (19795) | (14348) |
| Net issuance under equity plans | (434) | (825) |
| Stock-based compensation | 1793 | 2060 |
| &nbsp;&nbsp;&nbsp;Ending balance | 277767 | 324438 |
| **Accumulated other comprehensive loss** |  |  |
| Beginning balance, net of tax | (21647) | (22193) |
| Foreign currency translation adjustment | (39) | (29) |
| &nbsp;&nbsp;&nbsp;Ending balance, net of tax | (21686) | (22222) |
| &nbsp;&nbsp;&nbsp;Total shareholders' equity ending balance | $256082 | $302217 |

---

**NOTE 11:&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAXES**

Our income tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for any discrete items that are taken into account in the relevant period. Each quarter we update our estimate of the annual effective tax rate and, if our estimated tax rate changes, we make a cumulative adjustment. Our quarterly tax provision and quarterly estimate of our annual effective tax rate are subject to variation due to several factors, including variability in accurately predicting our full year pre-tax income or loss by jurisdiction, tax credits, government audit developments, changes in laws, regulations and administrative practices, valuation allowances recorded on deferred tax assets, and relative changes in expenses or losses for which tax benefits are not recognized. Additionally, our effective tax rate can be more or less volatile based on the amount of pre-tax income or loss. For example, the impact of discrete items, tax credits, and non-deductible expenses on our effective tax rate is greater when our pre-tax income or loss is lower.

We recognize deferred tax assets to the extent we believe it is more likely than not the asset will be realized. Quarterly, management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit the use of existing deferred tax assets, including future reversals of existing taxable temporary differences, projected taxable income, tax-planning strategies, carryback potential if permitted, and the results of recent operations. A significant piece of objective negative evidence is the existence of a three-year cumulative loss. Such objective negative evidence limits the ability of management to consider other subjective evidence, such as projected taxable income. When appropriate, we record a valuation allowance to reduce deferred tax assets to the amount that is more likely than not to be realized.

During the thirteen weeks ended March 29, 2026, we performed our deferred tax asset realizability assessments and, as a result, we maintained a valuation allowance against our U.S. federal, state and certain foreign deferred tax assets. Our conclusion was driven by U.S. and foreign pre-tax losses beginning in 2023 and continuing into 2026, combined with the non-cash goodwill impairment charge of $59.1 million recorded during fiscal 2024.

Our effective income tax rate for the thirteen weeks ended March 29, 2026 was (3.0)%. The difference between the statutory federal income tax rate of 21.0% and our effective tax rate was primarily due to the valuation allowance against our U.S. federal, state and certain foreign deferred tax assets.

Page - 16

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 12:&nbsp;&nbsp;&nbsp;&nbsp;NET INCOME (LOSS) PER SHARE**

Diluted common shares were calculated as follows:

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except per share data)*** | **March 29,<br>2026** | **March 30,<br>2025** |
| Net loss | $(19795) | $(14348) |
| Weighted average number of common shares used in basic net loss per common share | 30145 | 29698 |
| Dilutive effect of non-vested stock-based awards |  |  |
| &nbsp;&nbsp;Weighted average number of common shares used in diluted net loss per common share | 30145 | 29698 |
| Net loss per common share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.66) | $(0.48) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.66) | $(0.48) |
| Anti-dilutive shares | 2093 | 1501 |

---

**NOTE 13:&nbsp;&nbsp;&nbsp;&nbsp;SEGMENT INFORMATION**

Our operating segments and reportable segments are described below:

Our **PeopleReady** reportable segment provides contingent staffing through the PeopleReady operating segment. PeopleReady provides on-demand and skilled labor in a broad range of industries that include construction, transportation, manufacturing, retail, hospitality and energy.

Our **PeopleManagement** reportable segment provides contingent labor and outsourced industrial workforce solutions, primarily on-site at the client's facility, through the following operating segments, which we have aggregated into one reportable segment in accordance with U.S. GAAP:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *OnSite*: On-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing and distribution facilities; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Centerline*: Recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries.

Our **PeopleSolutions** reportable segment provides professional and specialized talent acquisition solutions, as well as workforce management and compliance services.

We evaluate performance based on segment revenue and segment profit (loss). Segment revenue is net of intercompany eliminations. Segment profit (loss) includes revenue, related cost of services, and ongoing operating expenses directly attributable to the reportable segment. Segment profit (loss) excludes goodwill impairment charges, depreciation and amortization expense, unallocated corporate general and administrative expense, interest and other income (expense), income taxes, and other costs and benefits not considered to be ongoing.

Page - 17

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

The following tables present our revenue from services by segment, with a reconciliation to total company revenue. The tables also present significant segment expense categories regularly provided to the chief operating decision-maker ("CODM"), our Chief Executive Officer, and included in the calculation of segment profit (loss). Cost of services and SG&A expense for the individual segments, as presented in the tables below, exclude certain costs and benefits that are also excluded from the calculation of segment profit (loss). Lastly, the tables include a reconciliation of segment profit (loss) to loss before tax expense.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
| | **March 29, 2026** | **March 29, 2026** | **March 29, 2026** | **March 29, 2026** |
|<br>***(in thousands)*** | **PeopleReady** | **PeopleManagement** | **PeopleSolutions** | **Total company** |
| Revenue from services | $225053 | $127257 | $46256 | $398566 |
| Cost of services | 178080 | 108504 | 31955 |  |
| Selling, general and administrative expense | 50275 | 15499 | 11638 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Segment profit (loss) | $(3302) | $3254 | $2663 | $2615 |
| Corporate unallocated expense |  |  |  | (5665) |
| Third-party processing fees for hiring tax credits |  |  |  | 100 |
| Amortization of software as a service assets |  |  |  | (1259) |
| Acquisition/integration costs |  |  |  | (16) |
| Goodwill impairment charge |  |  |  | (3656) |
| Workforce reduction costs |  |  |  | (1069) |
| Other costs, net |  |  |  | (2030) |
| Depreciation and amortization (inclusive of depreciation included in cost of services) |  |  |  | (6867) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations |  |  |  | (17847) |
| Interest and other income (expense), net |  |  |  | (1372) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss before tax expense |  |  |  | $(19219) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
| | **March 30, 2025** | **March 30, 2025** | **March 30, 2025** | **March 30, 2025** |
|<br>***(in thousands)*** | **PeopleReady** | **PeopleManagement** | **PeopleSolutions** | **Total company** |
| Revenue from services | $189305 | $135532 | $45417 | $370254 |
| Cost of services | 136523 | 115303 | 31017 |  |
| Selling, general and administrative expense | 55756 | 17335 | 12448 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Segment profit (loss) | $(2974) | $2894 | $1952 | $1872 |
| Corporate unallocated expense |  |  |  | (5794) |
| Third-party processing fees for hiring tax credits |  |  |  | (90) |
| Amortization of software as a service assets |  |  |  | (1093) |
| Acquisition/integration costs |  |  |  | (710) |
| Workforce reduction costs |  |  |  | (1400) |
| Other costs, net |  |  |  | (98) |
| Depreciation and amortization (inclusive of depreciation included in cost of services) |  |  |  | (6810) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations |  |  |  | (14123) |
| Interest and other income (expense), net |  |  |  | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss before tax expense |  |  |  | $(13930) |

---

Asset information by reportable segment is not presented as we do not manage our segments on a balance sheet basis.

Page - 18

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS *(unaudited)***<br>

**NOTE 14:&nbsp;&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENT**

On April 10, 2026, the Company entered into a cooperation agreement (the "Cooperation Agreement") with Eric H. Su, EHS Management LLC, and EHS Azure Opportunity Fund LP (collectively, "EHS"). Pursuant to the Cooperation Agreement, EHS irrevocably withdrew its previously announced director nominations for the Company's 2026 annual meeting of shareholders and its demand to inspect certain books and records of the Company. The Company agreed to, among other things, engage a director search firm to identify candidates for a new independent director (the "New Director") to be appointed to the Board of Directors of the Company (the "Board") on or prior to September 30, 2026, with the New Director to be mutually agreed upon by the Company and EHS. The Company further agreed to nominate the New Director for election at the Company's 2027 annual meeting of shareholders and to cap the size of the Board at ten directors during the term of the Cooperation Agreement. EHS agreed to, among other things, customary standstill, voting, mutual non-disparagement, and no-litigation obligations. The Cooperation Agreement will remain in effect until fourteen days following the Company's public release of its audited financial statements for the 2026 fiscal year, subject to an automatic extension if the Company achieves certain financial performance targets. The Company also agreed to reimburse EHS for up to $0.3 million of reasonable and documented out-of-pocket fees and expenses incurred in connection with its engagement with the Company and the negotiation and execution of the Cooperation Agreement.

Page - 19

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

---

| | |
|:---|:---|
| **Item 2.** | **MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** |

---

**COMMENT ON FORWARD-LOOKING STATEMENTS**

*Certain statements in this Form 10-Q, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements involve risks and uncertainties, and future events and circumstances could differ significantly from those anticipated in the forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "goal," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in our forward-looking statements, including the risks and uncertainties described in "Management's Discussion and Analysis of Financial Condition and Results of Operations" (Part I, Item 2 of this Form 10-Q),"Quantitative and Qualitative Disclosures about Market Risk" (Part I, Item 3 of this Form 10-Q), and "Risk Factors" (Part II, Item 1A of this Form 10-Q). Except as required by law, we undertake no duty to update or revise publicly any of the forward-looking statements after the date of this report or to conform such statements to actual results or to changes in our expectations, whether because of new information, future events, or otherwise.*

**BUSINESS OVERVIEW**

TrueBlue, Inc. (the "Company," "TrueBlue," "we," "us" and "our") is a leading provider of specialized workforce solutions that connect employers and talent. Client demand for contingent workforce solutions and outsourced recruiting services is cyclical and dependent on the overall strength of the economy and labor market, as well as trends in workforce flexibility.

We report our business as three distinct segments: PeopleReady, PeopleManagement and PeopleSolutions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***PeopleReady*** provides clients with dependable access to qualified associates for their on-demand, contingent general and skilled labor needs to supplement their permanent workforce, across a broad range of industries including construction, transportation, manufacturing, retail, hospitality and energy. PeopleReady connects our clients with individuals looking for on-demand, general temporary and temp-to-hire positions through our vast network of physical branches across all 50 states in the United States ("U.S.") and Puerto Rico. Augmenting our branch network, our proprietary mobile app, JobStack<sup>®</sup>, connects people with on-demand work 24 hours a day, seven days a week.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• PeopleManagement*** provides and manages contingent associates at clients' facilities through our Staff Management \| SMX ("Staff Management") and SIMOS Insourcing Solutions ("SIMOS") branded services throughout the U.S., Canada and Puerto Rico. Our client engagements include scalable recruiting, screening, hiring and management of the contingent workforce. We deploy dedicated management and service teams that work side-by-side with a client's full-time workforce and specialize in labor-intensive manufacturing, warehousing and distribution. Our proprietary hiring and workforce management software, Stafftrack<sup>®</sup>, enables us to recruit and connect the best candidates with on-site assignments. PeopleManagement also provides dedicated and contingent commercial drivers to the transportation and distribution industries through our Centerline Drivers ("Centerline") brand.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***PeopleSolutions*** provides clients with services focusing on professional and specialized talent acquisition, as well as workforce management and compliance, across a wide variety of industries and primarily in the U.S., Canada, the United Kingdom and Australia. PeopleSolutions provides recruitment process outsourcing ("RPO"), healthcare talent acquisition services, managed service provider ("MSP") solutions, and talent advisory services through our PeopleScout and Healthcare Staffing Professionals ("HSP") brands. Assisting our PeopleSolutions recruiting teams is our proprietary technology platform, Affinix<sup>®</sup>, which rapidly sources a qualified talent pool, and further engages candidates through a seamless digital experience.

Page - 20

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

**Fiscal first quarter of 2026 summary**

The following results are for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total company revenue grew 7.6% to $398.6 million, compared to $370.3 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total company gross profit declined 8.5% to $79.0 million compared to $86.3 million, resulting in a decline in gross profit as a percentage of revenue to 19.8%, compared to 23.3%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total company selling, general and administrative ("SG&A") expense improved 7.7% to $87.3 million, compared to $94.6 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We recorded a goodwill impairment charge of $3.7 million related to our HSP reporting unit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income tax expense was $0.6 million, compared to $0.4 million. We continue to maintain a valuation allowance against our U.S. federal, state and certain foreign deferred tax assets initially established in the fiscal second quarter of 2024, resulting in no current period income tax benefit for these jurisdictions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The items above resulted in a net loss of $19.8 million, compared to a net loss of $14.3 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• As of March 29, 2026, we had cash and cash equivalents of $24.1 million, outstanding debt of $73.9 million, and $36.0 million was unused on our borrowing base of our revolving credit agreement ("Amended Revolving Credit Facility"), resulting in total liquidity of $60.2 million.

Page - 21

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

**RESULTS OF OPERATIONS**

**Total company results**

The following table presents selected financial data:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages and per share data)*** | **Mar 29,<br>2026** | **% of revenue** | **Mar 30,<br>2025** | **% of revenue** |
| Revenue from services | $398566 |  | $370254 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | $79019 | 19.8% | $86342 | 23.3% |
| Selling, general and administrative expense | 87299 | 21.9 | 94621 | 25.6 |
| Depreciation and amortization (exclusive of depreciation included in cost of services) | 5911 | 1.5 | 5844 | 1.5 |
| Goodwill impairment charge | 3656 | 0.9 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (17847) | (4.5)% | (14123) | (3.8)% |
| Interest and other income (expense), net | (1372) |  | 193 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss before tax expense | (19219) |  | (13930) |  |
| Income tax expense | 576 |  | 418 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(19795) | (5.0)% | $(14348) | (3.9)% |
| Net loss per diluted share | $(0.66) |  | $(0.48) |  |

---

**Revenue from services**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29,<br>2026** | **Growth (decline) %** | **Segment % of total** | **Mar 30,<br>2025** | **Segment % of total** |
| Revenue from services: | Revenue from services: |  |  |  |  |
| &nbsp;&nbsp;PeopleReady | $225053 | 18.9% | 56.5% | $189305 | 51.1% |
| &nbsp;&nbsp;PeopleManagement | 127257 | (6.1)% | 31.9 | 135532 | 36.6 |
| &nbsp;&nbsp;PeopleSolutions | 46256 | 1.8% | 11.6 | 45417 | 12.3 |
| Total company | $398566 | 7.6% | 100.0% | $370254 | 100.0% |

---

Total company revenue grew 7.6% to $398.6 million for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year. The increase in revenue was primarily driven by growth within our skilled businesses, specifically in the energy and commercial driving industries. This growth was partially offset by declines within on-demand, on-site and permanent hiring, as business conditions continue to stabilize within these offerings.

***PeopleReady***

PeopleReady revenue grew 18.9% to $225.1 million for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year, primarily as a result of growth within our skilled businesses, specifically the energy industry. Growth from our skilled businesses was partially offset by declines within our on-demand business, as broader market conditions continue to stabilize.

***PeopleManagement***

PeopleManagement revenue declined 6.1% to $127.3 million for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year, primarily due to lower volumes within the OnSite business. This decline was partially offset by continued growth in our commercial driving business.

Page - 22

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

***PeopleSolutions***

PeopleSolutions revenue grew 1.8% to $46.3 million for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year. The acquisition of Healthcare Staffing Professionals, Inc. in early 2025 contributed 8.8% of the growth. Revenue for our PeopleScout business declined as labor market conditions have led to uncertainty around our clients' future workforce needs, and clients continue to experience less employee turnover while also facing cost pressures. This has resulted in clients reducing hiring volumes, sourcing candidates with internal resources, and initiating hiring freezes to control costs. Despite these challenges, we have expanded existing and new client relationships into higher skilled roles and in attractive end markets, positioning this business for future growth.

**Gross profit**

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **Mar 30, 2025** |
| Gross profit | $79019 | $86342 |
| Percentage of revenue | 19.8% | 23.3% |

---

Gross profit as a percentage of revenue declined 350 basis points to 19.8% for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year. Higher workers' compensation costs, driven by less favorable workers' compensation reserve adjustments, resulted in 220 basis points of contraction. Additionally, changes in revenue mix resulted in 130 basis points of contraction, primarily driven by revenue shifts toward our lower margin staffing businesses.

**SG&A expense**

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **Mar 30, 2025** |
| Selling, general and administrative expense | $87299 | $94621 |
| Percentage of revenue | 21.9% | 25.6% |

---

Total company SG&A expense improved by 7.7%, or $7.3 million, for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year, reflecting the effectiveness of the operational cost management actions we have implemented. These actions have enhanced the efficiency of our cost structure and position us to deliver stronger profitability as industry demand rebounds.

**Depreciation and amortization**

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **Mar 30, 2025** |
| Depreciation and amortization (exclusive of depreciation included in cost of services) | $5911 | $5844 |
| Percentage of revenue | 1.5% | 1.5% |

---

Depreciation and amortization increased for the thirteen weeks ended March 29, 2026, compared to the same period in the prior year. This was primarily due to higher amortization expense related to the acquisition of Healthcare Staffing Professionals, Inc. on January 31, 2025, which resulted in an additional month of amortization expense in the current period.

Page - 23

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

**Goodwill impairment charge**

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands)*** | **Mar 29, 2026** | **Mar 30, 2025** |
| Goodwill impairment charge | $3656 | $— |

---

We performed an interim impairment test as of the last day of our fiscal first quarter of 2026. As a result of this impairment test, we concluded that the carrying amount of the HSP reporting unit exceeded its estimated fair value. Thus, we recorded a non-cash goodwill impairment charge of $3.7 million, which was included in goodwill impairment charge on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen weeks ended March 29, 2026. The goodwill impairment was primarily driven by downward revisions to future projections associated with our HSP reporting unit, an increase in discount rate, and a decline in the market capitalization of similar publicly traded companies. The remaining goodwill balance for HSP as of March 29, 2026 was $13.7 million. See Note 6: *Goodwill* to our consolidated financial statements found in Item 1 of this Quarterly Report on Form 10-Q, for additional details.

**Income tax expense**

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **Mar 30, 2025** |
| Loss before tax expense | $(19219) | $(13930) |
| Income tax expense | $576 | $418 |
| Effective income tax rate | (3.0)% | (3.0)% |

---

Our tax provision and our effective tax rate are subject to variation due to several factors, including variability in accurately predicting our full year pre-tax income or loss by jurisdiction, tax credits, government audit developments, changes in laws, regulations and administrative practices, valuation allowances recorded on deferred tax assets, and relative changes in expenses or losses for which tax benefits are not recognized. Additionally, our effective tax rate can be more or less volatile based on the amount of pre-tax income or loss. For example, the impact of discrete items, tax credits, and non-deductible expenses on our effective tax rate is greater when our pre-tax income or loss is lower.

For the thirteen weeks ended March 29, 2026, our income tax expense is related primarily to our foreign operations. We continue to maintain a valuation allowance against our U.S. federal, state and certain foreign deferred tax assets, initially established in the fiscal second quarter of 2024, resulting in no income tax benefit for these jurisdictions. Our conclusions to maintain a valuation allowance were driven by U.S. and foreign pre-tax losses beginning in 2023 and continuing into 2026, combined with the significant non-cash goodwill impairment charge of $59.1 million recorded during fiscal 2024.

**Segment performance**

We evaluate performance based on segment revenue and segment profit (loss). Segment revenue is net of intercompany eliminations. Segment profit (loss) includes revenue, related cost of services, and ongoing operating expenses directly attributable to the reportable segment. Segment profit (loss) excludes goodwill impairment charges, depreciation and amortization expense, unallocated corporate general and administrative expense, interest and other income (expense), income taxes, and other costs and benefits not considered to be ongoing. See Note 13: *Segment Information*, to our consolidated financial statements found in Item 1 of this Quarterly Report on Form 10-Q, for additional details on our reportable segments, as well as a reconciliation of segment profit (loss) to loss before tax expense.

Segment profit (loss) should not be considered a measure of financial performance in isolation or as an alternative to net loss on the Consolidated Statements of Operations and Comprehensive Income (Loss) calculated in accordance with accounting principles generally accepted in the United States of America, and may not be comparable to similarly titled measures of other companies.

Page - 24

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

***PeopleReady*** segment performance was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **% of revenue** | **Mar 30, 2025** | **% of revenue** |
| Revenue from services | $225053 |  | $189305 |  |
| Cost of services | 178080 | 79.1% | 136523 | 72.1% |
| Selling, general and administrative expense | 50275 | 22.4% | 55756 | 29.5% |
| Segment loss | $(3302) | (1.5)% | $(2974) | (1.6)% |

---

PeopleReady segment loss grew $0.3 million for the thirteen weeks ended March 29, 2026, but improved as a percentage of revenue, compared to the same period in the prior year. The decline was primarily due to higher workers' compensation costs driven by less favorable workers' compensation reserve adjustments, as well as the continued growth within our skilled businesses, specifically the energy industry, which carries lower margins due to pass-through travel costs. These were partially offset by operational cost management actions, which have resulted in a more efficient cost structure.

***PeopleManagement*** segment performance was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **% of revenue** | **Mar 30, 2025** | **% of revenue** |
| Revenue from services | $127257 |  | $135532 |  |
| Cost of services | 108504 | 85.2% | 115303 | 85.1% |
| Selling, general and administrative expense | 15499 | 12.2% | 17335 | 12.8% |
| Segment profit | $3254 | 2.6% | $2894 | 2.1% |

---

PeopleManagement segment profit grew $0.4 million for the thirteen weeks ended March 29, 2026, and also improved as a percentage of revenue, compared to the same period in the prior year. Growth was primarily driven by a reduction in SG&A expense, which was the result of disciplined cost management actions to streamline our organizational structure and improve efficiency.

***PeopleSolutions*** segment performance was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands, except percentages)*** | **Mar 29, 2026** | **% of revenue** | **Mar 30, 2025** | **% of revenue** |
| Revenue from services | $46256 |  | $45417 |  |
| Cost of services | 31955 | 69.1% | 31017 | 68.3% |
| Selling, general and administrative expense | 11638 | 25.1% | 12448 | 27.4% |
| Segment profit | $2663 | 5.8% | $1952 | 4.3% |

---

PeopleSolutions segment profit grew $0.7 million for the thirteen weeks ended March 29, 2026, and also grew as a percentage of revenue, compared to the same period in the prior year. Growth was primarily driven by cost management actions to improve efficiency and scalability, as well as inorganic growth from the acquisition of Healthcare Staffing Professionals, Inc.

Page - 25

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

**LIQUIDITY AND CAPITAL RESOURCES**

We believe we have a strong financial position and sufficient sources of funding to meet our short- and long-term obligations. Our Amended Revolving Credit Facility provides for a revolving line of credit of up to $175.0 million, with an option to increase the amount by $150.0 million, subject to lender approval. As of March 29, 2026, we had $24.1 million in cash and cash equivalents and $73.9 million debt outstanding. Under the Amended Revolving Credit Facility, $11.4 million was utilized by outstanding standby letters of credit. As of March 29, 2026, our borrowing base was $121.3 million, leaving $36.0 million unused on our borrowing base.

Cash generated through our core operations is generally our primary source of liquidity. Our principal ongoing cash needs are to finance working capital, fund capital expenditures, repay outstanding Amended Revolving Credit Facility balances, and execute share repurchases. We may also need cash to fund future acquisitions. We manage working capital through timely collection of accounts receivable, which we achieve through focused collection efforts and tightly monitoring trends in days sales outstanding. While client payment terms are generally 90 days or less, we pay our associates daily and weekly, so additional financing through the use of our Amended Revolving Credit Facility is sometimes necessary to support working capital needs in times of revenue growth. We also manage working capital through efficient cost management and strategically timing payments of accounts payable.

We continue to make investments in online and mobile apps to increase the competitive differentiation of our services long-term and improve the efficiency of our service delivery model. In addition, we continue to transition our technology from on-premise software platforms to cloud-based software solutions, to increase automation and the efficiency of running our business.

Outside of ongoing cash needed to support core operations, our insurance carriers and certain state workers' compensation programs require us to collateralize a portion of our workers' compensation obligation, for which they become responsible should we become insolvent. On a regular basis, these entities assess the amount of collateral they will require from us relative to our workers' compensation obligation. Such amounts can increase or decrease independent of our assessments and reserves. We continue to have risk that these collateral requirements may be increased by our insurers due to our loss history and market dynamics. We generally anticipate that our collateral commitments will grow as our business grows. We pay our premiums and deposit our collateral, if required, in installments. The collateral typically takes the form of cash and cash-backed instruments, highly rated investment grade securities, letters of credit, and surety bonds. Restricted cash, cash equivalents and investments supporting our self-insured workers' compensation obligation are held in a trust at the Bank of New York Mellon ("Trust") and are used to pay workers' compensation claims as they are filed. See Note 7: *Workers' Compensation Insurance and Reserves*, and Note 4: *Restricted Cash, Cash Equivalents and Investments*, to our consolidated financial statements found in Item 1 of this Quarterly Report on Form 10-Q, for details on our workers' compensation program as well as the restricted cash, cash equivalents and investments held in Trust.

We have established investment policy directives for the Trust with the first priority to preserve capital, second to ensure sufficient liquidity to pay workers' compensation claims, third to diversify the investment portfolio and fourth to maximize after-tax returns. Trust investments must meet minimum acceptable quality standards. The primary investments include U.S. Treasury securities, U.S. agency debentures, U.S. agency mortgages, corporate securities and municipal securities. For those investments rated by nationally recognized statistical rating organizations the minimum ratings at time of purchase are:

---

| | | | |
|:---|:---|:---|:---|
| | **S&P** | **Moody's** | **Fitch** |
| Short-term rating | A-1/SP-1 | P-1/MIG-1 | F-1 |
| Long-term rating | A | A2 | A |

---

Total collateral commitments decreased $5.8 million during the thirteen-week period ended March 29, 2026, primarily due to the use of collateral to satisfy workers' compensation claims, as well as a decrease in collateral levels required by our insurance carriers, consistent with the $8.6 million decrease in workers' compensation claims reserve. See Note 9: *Commitments and Contingencies*, to our consolidated financial statements found in Item 1 of this Quarterly Report on Form 10-Q, for additional details on our workers' compensation commitments. We continue to actively manage workers' compensation cost by focusing on improving our associate safety programs and actively control costs with our network of service providers. These actions have had a positive impact creating favorable adjustments to workers' compensation liabilities recorded in prior periods. Continued favorable adjustments to our prior year workers' compensation liabilities are dependent on our ability to continue to aggressively lower accident rates and costs of our claims. Due to our progress in worker safety improvements and the resulting reduction in the frequency and severity of accident rates, we expect diminishing favorable adjustments to our workers' compensation liabilities going forward.

Page - 26

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

The following table provides an analysis of changes in our workers' compensation claims reserves:

---

| | | |
|:---|:---|:---|
| ***(in thousands)*** | **Mar 29, 2026** | **Dec 28, 2025** |
| Beginning balance | $96744 | $139792 |
| Self-insurance reserve expenses related to current year, net | 8799 | 34917 |
| Cash payments related to current year claims | (545) | (12557) |
| Cash payments related to claims from prior years | (11467) | (32727) |
| Changes to prior years' self-insurance reserve, net | (1341) | (19574) |
| Amortization of prior years' discount <sup>(1)</sup> | 1204 | (123) |
| Net change in excess claims reserve <sup>(2)</sup> | (5293) | (12984) |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 88101 | 96744 |
| Less current portion | 22931 | 24193 |
| Long-term portion | $65170 | $72551 |

---

(1)The discount is amortized over the estimated weighted average life. In addition, any changes to the estimated weighted average lives and corresponding discount rates for actual payments made are reflected in cost of services on the Consolidated Statement of Operations and Comprehensive Income (Loss) in the period when the changes in estimates are made.

(2)Changes to our claims above our self-insured limits ("excess claims") are discounted to an estimated net present value using the risk-free rates associated with the actuarially determined weighted average lives of our excess claims.

Restricted cash, cash equivalents and investments also includes collateral to support our non-qualified deferred compensation plan in the form of company-owned life insurance policies. Our non-qualified deferred compensation plan is managed by a third-party service provider, and the investments backing the company-owned life insurance policies align with the amount and timing of payments based on employee elections.

A summary of our cash flows for each period are as follows:

---

| | | |
|:---|:---|:---|
| | **Thirteen weeks ended** | **Thirteen weeks ended** |
|<br>***(in thousands)*** | **Mar 29, 2026** | **Mar 30, 2025** |
| Net cash used in operating activities | $(9779) | $(22115) |
| Net cash provided by (used in) investing activities | 3221 | (23968) |
| Net cash provided by financing activities | 7174 | 49369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | (323) | (230) |
| &nbsp;&nbsp;Net change in cash, cash equivalents and restricted cash and cash equivalents | $293 | $3056 |

---

**Cash flows from operating activities**

Operating cash flows consist of net loss adjusted for non-cash benefits and expenses, and changes in operating assets and liabilities.

As client demand improves, the result is generally an increase in accounts receivable and accounts payable. Accrued wages and benefits can fluctuate based on whether the period end requires the accrual of one or two weeks of payroll, the amount and timing of bonus payments, and timing of payroll tax payments.

Net cash used by accounts receivable during the thirteen weeks ended March 29, 2026 was primarily due to an increase in days sales outstanding of approximately four days compared to the fiscal fourth quarter of 2025, reflecting a higher percentage of receivables with longer payment terms, partially offset by a decrease in revenue. In addition, our workers' compensation claims reserve for estimated claims decreases as claims are paid, as was the case in the current period.

Page - 27

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

**Cash flows from investing activities**

Investing cash flows consist of capital expenditures, business acquisitions, net proceeds from divestiture, and purchases, sales, and maturities of restricted investments, which are managed in line with our workers' compensation collateral funding requirements and timing of claim payments.

Net cash provided by investing activities during the thirteen weeks ended March 29, 2026 was due to maturities of restricted investments, which were only partially reinvested due to lower workers' compensation collateral requirements. Cash provided was partially offset by capital expenditures including continued investments to upgrade our PeopleReady on-demand technology platform.

**Cash flows from financing activities**

Financing cash flows consist primarily of repurchases of common stock as part of our publicly announced share repurchase program, amounts to satisfy employee tax withholding obligations upon the vesting of restricted stock, the net change in our Amended Revolving Credit Facility, and proceeds from the sale of common stock through our employee stock purchase plan.

Net cash provided by financing activities during the thirteen weeks ended March 29, 2026 was due to draws on our Amended Revolving Credit Facility, primarily to finance working capital needs as revenue increased. While we did not execute share repurchases during the thirteen weeks ended March 29, 2026, $33.5 million remains available for repurchase under existing authorizations as of March 29, 2026.

Page - 28

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

**SUMMARY OF CRITICAL ACCOUNTING ESTIMATES**

Our critical accounting estimates are discussed in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations; Summary of Critical Accounting Estimates" in our Annual Report on Form 10-K for the fiscal year ended December 28, 2025. The following has been updated to reflect changes made during the thirteen weeks ended March 29, 2026.

**Goodwill**

We evaluate goodwill for impairment on an annual basis as of the first day of our fiscal second quarter, or whenever events or circumstances make it more likely than not that an impairment may have occurred. These events or circumstances could include a significant change in general economic conditions, deterioration in industry environment, changes in cost factors, declining operating performance indicators, legal factors, competition, client engagement, changes in the carrying amount of net assets, a sale or disposition of a significant portion of a reporting unit, or a sustained decrease in stock price. We monitor the existence of potential impairment indicators throughout the fiscal year.

***Goodwill***

We test for goodwill impairment at the reporting unit level. We consider our reporting units to be our operating segments or one level below that (the component level) based on our organizational structure. Our reporting units with remaining goodwill as of March 29, 2026 were Centerline, PeopleScout, and HSP.

When evaluating goodwill for impairment, we may first assess qualitative factors to determine whether it is more likely than not the fair value of a reporting unit is less than its carrying amount. Qualitative factors include macroeconomic conditions, industry and market conditions and overall company financial performance. If, after assessing the totality of events and circumstances, we determine that it is more likely than not the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary.

The quantitative impairment test, if necessary, involves comparing the fair value of each reporting unit to its carrying value, including goodwill. Fair value reflects the price a market participant would be willing to pay in a potential sale of the reporting unit. If the fair value exceeds the carrying value, we conclude that no goodwill impairment has occurred. If the carrying value exceeds the fair value, we recognize an impairment charge in an amount equal to the excess, not to exceed the carrying value of the goodwill. We consider a reporting unit's fair value to be substantially in excess of its carrying value at a 20% premium or greater.

Determining the fair value of a reporting unit when performing a quantitative impairment test involves the use of significant estimates and assumptions to evaluate the impact of operational and economic changes on each reporting unit. We estimate the fair value using a weighting of the income and market valuation approaches. The income approach applies a fair value methodology to each reporting unit based on discounted cash flows. This analysis requires significant estimates and judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested. We also apply a market approach, which develops a value correlation based on the market capitalization of similar publicly traded companies, referred to as a multiple, to apply to the operating results of the reporting units. The primary market multiples to which we compare are revenue and earnings before interest, taxes, depreciation, and amortization.

We base fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates.

Page - 29

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**MANAGEMENT'S DISCUSSION AND ANALYSIS**<br>

During the thirteen weeks ended March 29, 2026, management determined that a triggering event had occurred at our HSP reporting unit as a result of a lower Company stock price and market capitalization. An additional impairment indicator was downward revisions to future projections associated with our HSP reporting unit, as a result of reductions in government funding that impacted certain HSP clients. Therefore, we performed an interim goodwill impairment test for this reporting unit as of the last day of our fiscal first quarter. The weighted average cost of capital used in our most recent impairment test was risk-adjusted to reflect the specific risk profile of the HSP reporting unit and was 16.5%.

Based on our interim impairment test as of the last day of our fiscal first quarter of 2026, we concluded that the carrying amount of the HSP reporting unit exceeded its estimated fair value. Thus, we recorded a non-cash goodwill impairment charge of $3.7 million, which was included in goodwill impairment charge on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirteen weeks ended March 29, 2026. The goodwill impairment was primarily driven by downward revisions to future projections associated with our HSP reporting unit, a decline in discount rate, and a decline in market capitalization of similar publicly traded companies. The remaining goodwill balance for HSP as of March 29, 2026 was $13.7 million. Any significant adverse change in our near- or long-term projections or macroeconomic conditions could result in future impairment charges. We will continue to closely monitor the operational performance of this reporting unit.

**NEW ACCOUNTING STANDARDS**

See Note 1: *Summary of Significant Accounting Policies,* to our consolidated financial statements found in Item 1 of this Quarterly Report on Form 10-Q.

---

| | |
|:---|:---|
| **Item 3.** | **QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK** |

---

Our quantitative and qualitative disclosures about market risk are discussed in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the fiscal year ended December 28, 2025, and have not changed materially.

---

| | |
|:---|:---|
| **Item 4.** | **CONTROLS AND PROCEDURES** |

---

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms. Our disclosure controls and procedures are also designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

During the fiscal first quarter of 2026, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures at a reasonable assurance level, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level, as of March 29, 2026.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recently completed fiscal quarter that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

The certifications required by Rule 13a-14 of the Exchange Act are filed as exhibits 31.1 and 31.2, respectively, to this Quarterly Report on Form 10-Q.

Page - 30

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**PART II. OTHER INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **LEGAL PROCEEDINGS** |

---

See Note 9: *Commitments and Contingencies,* to our consolidated financial statements found in Part I, Item 1 of this Quarterly Report on Form 10-Q.

---

| | |
|:---|:---|
| **Item 1A.** | **RISK FACTORS** |

---

*This Form 10-Q should be read in conjunction with the risk factors set forth in Part I, Item 1A of our Annual Report filed on Form 10-K for the year ended December 28, 2025. With the exception of the risk factor noted below, which updates the specific risk factor in our Annual Report filed on Form 10-K for the year ended December 28, 2025, there have been no material changes from the risk factors previously disclosed therein.*

*Investing in our securities involves risk. In addition to the updated risk factor below and all other information set forth in this Quarterly Report on Form 10-Q, the risk factors described in Part I, Item 1A of our Annual Report filed on Form 10-K for the year ended December 28, 2025 should be considered in evaluating our future prospects. If any of the events described therein occur, our business, financial condition, results of operations, liquidity, or access to the capital markets could be materially and adversely affected.*

***Actions of activist shareholders could cause us to incur substantial costs, divert management's attention and resources, disrupt our business and impact the trading value of our securities.***

We value constructive input from investors and regularly engage in dialogue with our shareholders regarding strategy and performance. Activist shareholders or others who disagree with the composition of the Board of Directors, our strategy or the way the company is managed have sought and may again seek to effect change through various strategies and channels, such as through commencing a proxy contest, making public statements critical of our performance or business, or engaging in other similar activities.

Responding to shareholder activism can be costly and time-consuming, be disruptive of our operations, and divert the attention of management and our employees from strategic initiatives. Activist campaigns can create perceived uncertainties as to our future direction, strategy, or leadership and may result in the loss of potential business opportunities, harm our ability to attract and retain employees, investors, and clients, and cause our stock price to experience periods of volatility or stagnation. The process of defending against such activities can divert management's focus from operating our business and implementing our strategic initiatives, and can adversely affect our business, financial condition, and results of operations.

---

| | |
|:---|:---|
| **Item 2.** | **UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** |

---

The table below includes repurchases of our common stock pursuant to publicly announced plans or programs and those not made pursuant to publicly announced plans or programs during the thirteen weeks ended March 29, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number**<br>**of shares**<br>**purchased** | **Weighted**<br>**average price**<br>**paid per**<br>**share** | **Total number of shares<br>purchased as part of<br>publicly announced plans<br>or programs** | **Approximate dollar value that**<br>**may yet be purchased under**<br>**plans or programs at period**<br>**end (1)** |
| 12/29/2025 through 01/25/2026 |  | $— |  | $33.5 million |
| 01/26/2026 through 02/22/2026 | 845 | $4.32 |  | $33.5 million |
| 02/23/2026 through 03/29/2026 | 324 | $3.66 |  | $33.5 million |
| Total | 1169 | $4.14 |  |  |

---

(1)On January 31, 2022, our Board of Directors authorized a $100.0 million addition to our share repurchase program of our outstanding common stock. The share repurchase program does not obligate us to acquire any particular amount of common stock and does not have an expiration date. As of March 29, 2026, $33.5 million remains available for repurchase under the existing authorization.

---

| | |
|:---|:---|
| **Item 3.** | **DEFAULTS UPON SENIOR SECURITIES** |

---

Not applicable.

Page - 31

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

---

| | |
|:---|:---|
| **Item 4.** | **MINE SAFETY DISCLOSURES** |

---

Not applicable.

---

| | |
|:---|:---|
| **Item 5.** | **OTHER INFORMATION** |

---

**Trading plans**

During the fiscal first quarter of 2026, none of our directors or executive officers adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as such terms are defined in paragraphs (a) and (c), respectively, of Item 408 of Regulation S-K promulgated under the Securities Act of 1933, as amended.

Page - 32

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

---

| | |
|:---|:---|
| **Item 6.** | **INDEX TO EXHIBITS** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Incorporated by reference** | **Incorporated by reference** | **Incorporated by reference** |
|<br>**Exhibit number** |<br>**Exhibit description** |<br>**Filed herewith** | **Form** | **File no.** | **Date of first filing** |
| 3.1 | <u>[Amended and Restated Articles of Incorporation.](https://www.sec.gov/Archives/edgar/data/768899/000076889916000078/tbiexhibit32amendedandrest.htm)</u> |  | 8-K | 001-14543 | 05/12/2016 |
| 3.2 | <u>[Amended and Restated Bylaws.](https://www.sec.gov/Archives/edgar/data/768899/000076889917000046/trueblueamendedandrestated.htm)</u> |  | 10-Q | 001-14543 | 10/30/2017 |
| 3.3 | <u>[Articles of Amendment for the Series A Junior Participating Preferred Stock, as filed with the Secretary of State of Washington on May 14, 2025 (incorporated by reference to Exhibit 3.1 to the Company's Registration Statement on Form 8-A, filed with the Securities and Exchange Commission on May 14, 2025, File No. 001-14543).](https://www.sec.gov/Archives/edgar/data/768899/000114036125018971/ef20049037_ex3-1.htm)</u> |  | 8-K | 001-14543 | 05/14/2025 |
| 10.1 | <u>[C](https://www.sec.gov/Archives/edgar/data/768899/000199937126008137/ex10-1.htm)[ooperation Agreement, dated April 10, 2026, by and](https://www.sec.gov/Archives/edgar/data/768899/000199937126008137/ex10-1.htm)[between TrueBlue, Inc. and Eric H Su, EHS Management LLC, and EHS Azure Opportunity Fund LP](https://www.sec.gov/Archives/edgar/data/768899/000199937126008137/ex10-1.htm)[.](https://www.sec.gov/Archives/edgar/data/768899/000199937126008137/ex10-1.htm)</u> |  | 8-K | 001-14543 | 04/13/2026 |
| 10.2\* | <u>[Form Performance Share Unit Award for grants on or after February 20, 2026 (One-Year Performance Period).](tbi10q032926ex102.htm)</u> | X |  |  |  |
| 31.1 | <u>[Certification of Taryn R. Owen, Chief Executive Officer of TrueBlue, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](tbi10q032926ex311.htm)</u> | X |  |  |  |
| 31.2 | <u>[Certification of Carl R. Schweihs, Chief Financial Officer of TrueBlue, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](tbi10q032926ex312.htm)</u> | X |  |  |  |
| 32.1 | <u>[Certification of Taryn R. Owen, Chief Executive Officer of TrueBlue, Inc. and Carl R. Schweihs, Chief Financial Officer of TrueBlue, Inc., Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](tbi10q032926ex321.htm)</u> | X |  |  |  |
| 101 | The following financial statements from the Company's 10-Q, formatted as Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations and Comprehensive Income (Loss), (iii) Consolidated Statements of Cash Flows, and (iv) Notes to consolidated financial statements. | X |  |  |  |
| 104 | Cover page interactive data file - The cover page from this Quarterly Report on Form 10-Q is formatted as Inline XBRL | X |  |  |  |

---

\* *Indicates a management contract or compensatory plan or arrangement*

**Copies of Exhibits may be obtained upon request directed to Mr. Garrett Ferencz, TrueBlue, Inc., PO Box 2910, Tacoma, Washington, 98401 and many are available at the SEC's website found at www.sec.gov.**

Page - 33

------

<u>[**Table of Contents**](#i063995e8228341da9579d946ba4e2af3_7)</u>

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **TrueBlue, Inc.**<br>***/s/ Taryn R. Owen*** |<br>**5/5/2026** |
|  | Signature | Date |
| By: | Taryn R. Owen, Chief Executive Officer and President |  |
|  | ***/s/ Carl R. Schweihs*** | **5/5/2026** |
|  | Signature | Date |
| By: | Carl R. Schweihs, Chief Financial Officer and Executive Vice President |  |
|  | ***/s/ Brian Capone*** | **5/5/2026** |
|  | Signature | Date |
| By: | Brian Capone, Chief Accounting Officer, Senior Vice President |  |

---

Page - 34

## Exhibit 10.2

**EXHIBIT 10.2**

**TRUEBLUE, INC.**

**PERFORMANCE SHARE UNIT GRANT NOTICE**

**("Grant Notice")**

(TrueBlue 2016 Omnibus Incentive Plan as Amended and Restated)

TrueBlue, Inc. (the "Company"), pursuant to its TrueBlue 2016 Omnibus Incentive Plan as Amended and Restated (the "Plan"), grants to Employee ("Participant"), as of the Date of Grant, the number of performance share units ("Performance Share Units," "PSUs," or "Units") set forth below (the "Award"). Each Performance Share Unit granted represents the contingent right to receive one share of the Company's common stock ("Share"). The PSUs granted hereunder are subject to the terms and conditions in this Grant Notice and the terms of the Plan, which is incorporated by reference herein in its entirety. Copies of the Plan are available upon request.

Target Number of PSUs Granted (Schedule I - EBITDA):&nbsp;&nbsp;&nbsp;&nbsp;**S**ee Merrill Benefits Online Portal

Date of Grant:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**«Date_of_Grant»** 

Performance Period:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**«Performance_Period»** 

Vesting Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**«Vesting Date»** 

Grant Notice Confirmation Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**«Confirmation_Date»**

**1.&nbsp;&nbsp;&nbsp;&nbsp;VESTING TERMS:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Performance Vesting</u>. The PSUs will vest, if and as provided below, on the Vesting Date. The number of PSUs under the Award that actually vest and that will be settled shall be determined on the basis of the completion of the requirements set forth in Section 1(b) below. The number of PSUs that vest are referred to as the "Vested PSUs".

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Performance Determination</u>. The attached Schedule I specifies the performance metrics required to be attained during the Performance Period in order for the PSUs to become eligible to vest. As soon as reasonably practicable following the end of the Performance Period, the Compensation Committee of the Board of Directors of the Company (the "Committee") shall determine in its sole discretion the attainment level of the performance metric. On the basis of the determined level of attainment of the performance metric, the Target PSUs will be multiplied by the applicable percentage determined in accordance with the performance matrix set forth in Schedule I, as applicable. The number of PSUs resulting from such determination shall constitute that maximum number of PSUs in which the Participant may vest under this Award.

**2. ISSUANCE OF SHARES OF STOCK:&nbsp;&nbsp;&nbsp;&nbsp;**As soon as practicable following the Vesting Date (but in no event later than thirty (30) days after the Vesting Date and in all cases by the March 15<sup>th</sup> following the Vesting Date), the Company shall issue to the Participant, on a one-for-one basis, a number of Shares equal to the number of Vested PSUs, provided in each case that Participant has satisfied its tax withholding obligations with respect to such vesting as described below (the "Settlement Date"). Shares, in a number equal to the number of Vested PSUs, will be issued by the Company in the name of Participant by electronic book-entry transfer or credit of such shares to Participant's account maintained with such brokerage firm or other custodian as the Company determines. Participant shall thereafter have all the rights of a stockholder of the Company with respect to such Shares.

**3. VESTING AND FORFEITURE OF PERFORMANCE SHARE UNITS.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination of Employment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;If you are terminated with Cause by the Company, or its subsidiaries or affiliates, or you terminate your employment with the Company, or its subsidiaries or affiliates, without Good Reason all vesting in Units will cease and any Units which are not vested shall be forfeited and ownership of such Units shall return to the Company on your employment termination date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of determining the vesting of Units only, if you are terminated by the Company, or its subsidiaries or affiliates, without Cause, or you terminate your employment with the Company, or its subsidiaries or affiliates, for Good Reason, you will be eligible to vest in that number of PSUs that are earned pursuant to the performance vesting provisions set forth in this Grant Notice and on Schedule I hereto, pro-rated based on the

------

portion of the Company's three fiscal years beginning with the grant year that you were employed, as increased by any period of accelerated vesting to which you are entitled in your employment agreements, if any. Any such pro-rated number of PSUs will be settled in Shares within seventy-four (74) days following the later of (1) your date of termination or (2) the completion of the Performance Period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Change in Control</u>. If there is a Change in Control, as defined in the Plan while you are employed by the Company or any subsidiary or affiliate of the Company, the PSUs shall be treated in accordance with the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Retirement</u>. If you retire (voluntarily terminate your employment) from the Company and are (i) at least 55 years of age, and (ii) have completed 10 years of service to the Company, then you will be eligible to vest in that number of PSUs that are earned pursuant to the performance vesting provisions set forth in this Grant Notice and on Schedule I hereto, pro-rated based on the portion of the Company's three fiscal years beginning with the grant year that you were employed. Any such pro-rated number of PSUs will be settled in Shares within seventy-four (74)days following the later of (1) your date of retirement or (2) the completion of the Performance Period. Death; Disability. In the event of Participant's death or Separation of Service due to Disability, each as defined in the Plan, the PSUs shall be treated in accordance with the Plan.

**4. DIVIDEND EQUIVALENTS.&nbsp;&nbsp;&nbsp;&nbsp;**In addition to the PSUs, the Company hereby grants to Participant, with respect to each Vested PSU, an amount equal to the cash dividend the Company pays on each Share between the Date of Grant and the Settlement Date (each a "Dividend Equivalent Amount"). Following the Date of Grant, the Company will establish a bookkeeping account (a "Dividend Equivalent Account") and credit the Dividend Equivalent Amounts to such account through the Settlement Date. On the Settlement Date, the balance in your Dividend Equivalent Account shall be converted into an additional number of Vested PSUs determined by dividing the balance of the Dividend Equivalent Account by the Fair Market Value of a Share on the Settlement Date, rounded up or down to the nearest whole number. Your Dividend Equivalent Account will be subject to the same conditions as the underlying PSUs with respect to which Dividend Equivalent Amounts were paid, including, without limitation, the vesting conditions and the provisions governing time and form of settlement applicable to the underlying PSUs. Unless expressly provided otherwise, as used elsewhere in this Grant Notice, "PSUs" shall include any Dividend Equivalent Amounts payable on such PSUs under this Grant Notice.

**5. NUMBER OF SHARES OF PERFORMANCE SHARE UNITS.&nbsp;&nbsp;&nbsp;&nbsp;**The number of Units referenced in your Grant Notice may be adjusted from time to time for changes in the Company's capital structure at the Board's sole discretion, as provided in the Plan.

**6. OWNERSHIP AND TAXATION UPON VESTING IN PERFORMANCE SHARE UNITS.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Until you vest in your Units, the Units shall be held by the Company on your behalf. Your ownership of the Units shall be evidenced by an appropriate entry on the books of the Company or of a duly authorized agent of the Company, or other appropriate means as determined by the Company. In the event ownership of Company common stock is prohibited due to foreign exchange, securities regulations, or other provisions of applicable law, you, or in the event of your death, your legal representative, shall receive cash proceeds in an amount equal to the value of the shares of common stock otherwise distributable to you upon vesting of the Units, net of the satisfaction of the requirements of Section 6(b) below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;You shall pay, or make adequate arrangements satisfactory to the Company to pay, any sums required to satisfy the federal, state, local, and foreign tax withholding obligations of the Company or its subsidiaries or affiliates, if any, which arise in connection with your vesting in or settlement of the Units. You hereby authorize the Company (or a subsidiary or affiliate of the Company that employs you), to withhold from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for, sums to satisfy the required tax withholdings. Alternatively, or in addition, if permissible under local law, the Company may (i) sell or arrange for the sale of a portion of the earned shares to satisfy the withholding obligation and/or (ii) reclaim ownership of a portion of the Units, provided that the Company shall retake ownership in only the amount of shares necessary to satisfy the minimum withholding amount. You shall pay to the Company (or the subsidiary or affiliate of the Company that employs you) any amount needed to pay the tax withholding obligations that cannot be satisfied by the means previously described.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Until your Units are converted to Shares and are evidenced by a stock certificate, appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company, or other appropriate means, you shall have no right to vote or receive dividends or any other rights as a shareholder with respect to such Units. No adjustment will be made for a dividend or other right for which the record date is prior to the date you are recorded as the owner of the Shares, unless the Committee provides you with a dividend equivalent right pursuant to the Plan

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;By accepting the Grant Notice through accepting the PSU grant at the Merrill Lynch website, you agree not to sell any of the Shares in which you become vested at a time when applicable laws or Company policies prohibit a sale.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;All Units are only convertible into Shares. At the time of vesting and converting of Units into Shares, you have no right to convert any Unit directly into cash. After Units have been converted into Shares, you may sell, trade, or otherwise dispose of such Shares as you wish, subject to applicable laws, rules, and agreements regarding such Shares.

**7. TRANSFERABILITY.&nbsp;&nbsp;&nbsp;&nbsp;**Your right in the Units awarded under this PSU grant and any interest therein may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner, other than by will or by the laws of descent or distribution, prior to the settlement of such Units.

**8. PERFORMANCE SHARE UNIT AWARD IS NOT A SERVICE CONTRACT.&nbsp;&nbsp;&nbsp;&nbsp;**Your award of Units is not an employment or service contract, and nothing in your award shall be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company or a subsidiary or affiliate of the Company, or any obligation on the part of the Company or a subsidiary or affiliate of the Company to continue your employment. In addition, nothing in your award shall obligate the Company or a subsidiary or affiliate of the Company, their respective shareholders, boards of directors, officers, or employees to continue any relationship that you might have as a Director or Consultant for the Company or a subsidiary or affiliate of the Company.

**9. GOVERNING PLAN DOCUMENT.&nbsp;&nbsp;&nbsp;&nbsp;**Your Units award is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your award and is further subject to all interpretations, amendments, rules, and regulations which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the terms of an employment agreement, Change in Control Agreement, this Grant Notice, and the Plan, the documents shall govern in the order listed herein, to the extent permitted by the terms of the Plan. Participant further acknowledges that as of the Date of Grant, this Grant Notice, Participant's employment agreement, and the Plan set forth the entire understanding between Participant and the Company regarding the acquisition of the PSU granted hereunder and supersede all prior oral and written agreements on that subject. Establishing a brokerage account as set forth below and/or accepting the PSU granted hereunder shall constitute agreement to the terms above and any other referenced terms.

**10. ACKNOWLEDGEMENTS:&nbsp;&nbsp;&nbsp;&nbsp;**Unless Participant contacts the Company's Chief Legal Officer's office in writing within 30 days of the date of this Grant Notice, Participant acknowledges receipt of, and understands and agrees to, this Grant Notice and understands that a copy of the Plan is available upon request.

**11. STOCKHOLDER RIGHTS.&nbsp;&nbsp;&nbsp;&nbsp;**You will not be deemed to be the holder of and will not have any of the rights of a holder or owner of any Shares represented by your Units until your Units have been earned and converted into Shares and ownership of such Shares is evidenced as set forth in Section 2 above. Units do not make you eligible to receive any dividends, voting powers, or any other shareholder rights associated with Shares.

**12. GOLDEN PARACHUTE TAXES.&nbsp;&nbsp;&nbsp;&nbsp;**In the event that any amounts paid or deemed paid to you in connection with the Units are deemed to constitute "excess parachute payments" as defined in Code Section 280G (taking into account any other payments made to you under the Plan and any other compensation paid or deemed paid to you), or if you are deemed to receive an "excess parachute payment" by reason of the acceleration of vesting of your Units granted under the Plan due to a Change in Control (as defined in the Change in Control Agreement) or a Corporate Transaction (as defined in the Plan), the amount of such payments or deemed payments shall be reduced (or, alternatively, the number of Performance Share Units that become 100% earned shall be reduced), so that no such payments or deemed payments shall constitute excess parachute payments. The determination of whether a payment or deemed payment constitutes an excess parachute payment shall be in the sole discretion of the Company's Board.

------

**13. CODE SECTION 409A.&nbsp;&nbsp;&nbsp;&nbsp;**This award shall be interpreted in such a manner that all provisions relating to the settlement of the award are exempt from the requirements of Code Section 409A as "short-term deferrals" as described in Code Section 409A. This award and payments made pursuant to this Grant Notice and the Plan are intended to qualify for an exemption from or comply with Code Section 409A. Notwithstanding any other provision in this Grant Notice and the Plan, the Company, to the extent it deems necessary or advisable in its sole discretion, reserves the right, but shall not be required, to unilaterally amend or modify this Grant Notice and/or the Plan so that the RSUs granted to the Participant qualify for exemption from or comply with Code Section 409A; provided, however, that the Company makes no representations that the RSUs shall be exempt from or comply with Code Section 409A and makes no undertaking to preclude Code Section 409A from applying to the RSUs. Nothing in this Grant Notice or the Plan shall provide a basis for any person to take action against the Company or any Subsidiary or Affiliate based on matters covered by Code Section 409A, including the tax treatment of any amount paid or Award made under this Grant Notice, and neither the Company nor any of its Subsidiaries or Affiliates shall under any circumstances have any liability to any Participant or his or her estate or any other party for any taxes, penalties or interest imposed under Code Section 409A for any amounts paid or payable under this Grant Notice.

**14. DATA PRIVACY CONSENT.&nbsp;&nbsp;&nbsp;&nbsp;**In order to administer the Plan and to implement or structure future equity grants, the Company and certain agents thereof (together, the "Relevant Companies") may process any and all personal or professional data, including but not limited to Social Security or other identification numbers, home address, and telephone number, date of birth, and other information that is necessary or desirable for the administration of the Plan (the "Relevant Information"). By receiving the Grant Notice, the Participant (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Participant may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Participant shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.

**TRUEBLUE, INC.**

By:

Name:&nbsp;&nbsp;&nbsp;&nbsp;Garrett R. Ferencz

Title:&nbsp;&nbsp;&nbsp;&nbsp;EVP, Chief Legal Officer

Date:&nbsp;&nbsp;&nbsp;&nbsp;[Insert Date]

------

**TRUEBLUE, INC.**

**PERFORMANCE SHARE UNIT GRANT NOTICE**

**Schedule I** 

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION** 

I, Taryn R. Owen, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of TrueBlue, Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 5, 2026

---

| |
|:---|
| */s/ Taryn R. Owen* |
| Taryn R. Owen |
| Chief Executive Officer<br>(Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2** 

**CERTIFICATION**

I, Carl R. Schweihs, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of TrueBlue, Inc.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 5, 2026&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| */s/ Carl R. Schweihs* |
| Carl R. Schweihs |
| Chief Financial Officer<br>(Principal Financial Officer) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

We, Taryn R. Owen, the chief executive officer of TrueBlue, Inc. (the "company"), and Carl R. Schweihs, the chief financial officer of the company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;The Quarterly Report of the company on Form 10-Q, for the fiscal period ended March 29, 2026 (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the company.

---

| | |
|:---|:---|
| */s/ Taryn R. Owen* | */s/ Carl R. Schweihs* |
| Taryn R. Owen | Carl R. Schweihs |
| Chief Executive Officer<br>(Principal Executive Officer) | Chief Financial Officer<br>(Principal Financial Officer) |

---

May 5, 2026

A signed original of this written statement required by Section 906 has been provided to TrueBlue, Inc. and will be retained by TrueBlue, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

<br>